|
|
|
|
glioblastoma
A general term that refers to malignant astrocytoma, a type of brain tumor. (National Cancer Institute)
Temodar® Plus Radiation Therapy Improves Outcomes in Patients ... Mar 15, 2005
...for Research and Treatment of Cancer (EORTC) and the National Cancer Institute of Canada (NCIC) have reported that patients with glioblastoma multiforme (GBM ... Cancer Consultants (press release),
Approval for Temodar (temozolomide) capsules for newly diagnosed ... Mar 16, 2005
Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM ... News-Medical.net,
Temozolomide Brings New Hope for Glioblastoma Patients Mar 9, 2005
...of a novel chemotherapy agent, Temozolomide (brand name: Temodal(R)) to radiation therapy increases survival in patients suffering from glioblastoma, a very ... RxPG NEWS,
Radiotherapy plus Concomitant and Adjuvant Temozolomide for ... Mar 9, 2005
Background Glioblastoma, the most common primary brain tumor in adults, is usually rapidly fatal. The current standard of care for ... New England Journal of Medicine (subscription),
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma Mar 9, 2005
DNA-repair gene by promoter methylation compromises DNA repair and has been associated with longer survival in patients with glioblastoma who receive ... New England Journal of Medicine (subscription),
'Huge advance' in treating brain tumours Mar 10, 2005
...temozolomide marks the first advance in three "frustrating" decades of trying to control the most deadly form of brain cancer, glioblastoma, the researchers say ... Globe and Mail,
New drug offers hope to brain cancer victims Mar 9, 2005
While not a cure, the drug temozolomide marks the first advance in treating glioblastoma in three “frustrating� decades of trying to control the disease ... Globe and Mail,
Drug offers first advance in 30 years for treating deadly brain ... Mar 11, 2005
While not a cure, the drug temozolomide marks the first advance in treating glioblastoma in three "frustrating" decades of trying to control the disease, the ... Canada.com,
Brain tumour survivors live longer with combo therapy: study Mar 10, 2005
...cancer. Far from a cure, it's still the best news in years for patients with glioblastoma, an aggressive and deadly form of cancer. ... CBC Calgary,
Drug boosts brain tumour treatment Mar 10, 2005
...researchers has found. While not a cure, the drug temozolomide marks the first advance in treating glioblastoma in three decades. "We have ... Toronto Star,
Inotek Pharmaceuticals Announces Commencement of Enrollment in ... Mar 8, 2005
Corporation announced today that it has commenced enrollment in a Phase 1b/2a trial for its lead compound, INO-1001, in patients with Glioblastoma Multiforme. ... Business Wire (press release),
Saginaw-area researcher vies for funding to research brain cancer Feb 20, 2005
...(AP) — Glioblastoma, a form of brain cancer that kills thousands of Americans annually, is in the cross-hairs of a Michigan researcher. ... MLive.com,
Researcher closes in on brain cancer cure Feb 20, 2005
An insidious cancer that destroys the brain and kills thousands of Americans annually, glioblastoma is in the cross-hairs of the Saginaw Township researcher. ... The Saginaw News,
Chemotherapy found to help brain tumour patients Mar 10, 2005
...with physicians across Canada and Europe, found that using chemotherapy during and after radiation treatment helped patients with glioblastoma multiforme - the ... Edmonton Sun,
Chemotherapy Offers Some Promise in Treating Brain Tumors Mar 9, 2005
...options. Most adults diagnosed with glioblastoma will die within two years, even if they're treated with surgery and radiotherapy. ... Forbes
Combo Treatment More Effective for Brain Cancer Mar 9, 2005
The investigators explain most people with the type of cancer known as glioblastoma receive surgery to remove as much of the cancer as safely possible. ... Ivanhoe
Archives: The following articles may no longer be available on the web. If you want to inquire on a particular article, please contact the source publication (listed in parentheses).
Guilford Pharmaceuticals Expands Marketing and Distribution ... May 17, 2004
GLIADEL® is currently approved for use in 13 countries outside of the United States and Canada to treat recurrent glioblastoma multiforme, an aggressive form ... Yahoo News (press release) - May 17, 2004
... GLIADEL® is currently approved for use in 13 countries outside of the United States and Canada to treat recurrent glioblastoma multiforme, an aggressive form ...
Guilford Pharmaceuticals Expands Marketing and Distribution ... PR Newswire (press release) - May 17, 2004
... GLIADEL(R) is currently approved for use in 13 countries outside of the United States and Canada to treat recurrent glioblastoma multiforme, an aggressive form ...
Source: Xenova Group PLCPrimeZone (press release) - May 11, 2004
The initial Phase III clinical trial is designed to enrol 323 patients with non-resectable, progressive or recurrent Glioblastoma Multiforme (GBM) who have ...
Sangamo BioSciences to Make 16 Presentations at the 7th Annual ... Yahoo News (press release) - May 17, 2004
... Poster. -- Abstract # 649 Repression of Vascular Endothelial Growth Factor-A Over-Expression in Glioblastoma Cells Using Engineered Zinc-Finger Transcription ...
Learn more about Bernard JuurlinkStarPhoenix
Guilford Pharmaceuticals Expands Marketing and Distribution ... May 17, 2004
GLIADEL(R) is currently approved for use in 13 countries outside of the United States and Canada to treat recurrent glioblastoma multiforme, an aggressive form ... PR Newswire (press release) - May 17, 2004
... GLIADEL(R) is currently approved for use in 13 countries outside of the United States and Canada to treat recurrent glioblastoma multiforme, an aggressive form ...
Source: Xenova Group PLCPrimeZone (press release) - May 11, 2004
The initial Phase III clinical trial is designed to enrol 323 patients with non-resectable, progressive or recurrent Glioblastoma Multiforme (GBM) who have ...
Sangamo BioSciences to Make 16 Presentations at the 7th Annual ... Yahoo News (press release) - May 17, 2004
... Poster. -- Abstract # 649 Repression of Vascular Endothelial Growth Factor-A Over-Expression in Glioblastoma Cells Using Engineered Zinc-Finger Transcription ...
Learn more about Bernard JuurlinkStarPhoenix
Source: Xenova Group PLC May 11, 2004
The initial Phase III clinical trial is designed to enrol 323 patients with non-resectable, progressive or recurrent Glioblastoma Multiforme (GBM) who have ... PrimeZone (press release) - May 11, 2004
The initial Phase III clinical trial is designed to enrol 323 patients with non-resectable, progressive or recurrent Glioblastoma Multiforme (GBM) who have ...
Sangamo BioSciences to Make 16 Presentations at the 7th Annual ... Yahoo News (press release) - May 17, 2004
... Poster. -- Abstract # 649 Repression of Vascular Endothelial Growth Factor-A Over-Expression in Glioblastoma Cells Using Engineered Zinc-Finger Transcription ...
Learn more about Bernard JuurlinkStarPhoenix
Sangamo BioSciences to Make 16 Presentations at the 7th Annual ... May 17, 2004
Poster. -- Abstract # 649 Repression of Vascular Endothelial Growth Factor-A Over-Expression in Glioblastoma Cells Using Engineered Zinc-Finger Transcription ... Yahoo News (press release) - May 17, 2004
... Poster. -- Abstract # 649 Repression of Vascular Endothelial Growth Factor-A Over-Expression in Glioblastoma Cells Using Engineered Zinc-Finger Transcription ...
Learn more about Bernard JuurlinkStarPhoenix
Learn more about Bernard Juurlink May 13, 2004
Schultke was recently sent to a synchrotron in Daresbury, England to collect diffraction patterns from tumor tissue samples taken from glioblastoma patients. ... StarPhoenix
NeoPharm Announces New Clinical Trial Data for IL13-PE38QQR in ... May 6, 2004
...data in support of the Company's Phase III PRECISE Trial study of IL13-PE38QQR, the Company's novel tumor-targeting agent for glioblastoma multiforme, was ... Business Wire (press release) - May 6, 2004
... data in support of the Company's Phase III PRECISE Trial study of IL13-PE38QQR, the Company's novel tumor-targeting agent for glioblastoma multiforme, was ...
Lawsuit shocker: Docs gave mom cancerBoston Herald
Lawsuit shocker: Docs gave mom cancer May 13, 2004
...back.''. Yoshida said his mother was not told that the kidney donor had died of a fast-moving form of brain cancer called glioblastoma. ... Boston Herald
Family Sues Over Kidney Transplant Death May 13, 2004
He said his mother wasn't told before the Feb. 4, 2002, transplant that the donor died of a fast-moving form of brain cancer called glioblastoma. ... Yahoo News - May 13, 2004
... He said his mother wasn't told before the Feb. 4, 2002, transplant that the donor died of a fast-moving form of brain cancer called glioblastoma. ...
With SPA Agreement, Xenova Plans Two TransMID Phase IIIsBioWorld Online (subscription) - May 11, 2004
... Each of the trials is designed to enroll 323 patients with non-resectable, progressive or recurrent glioblastoma multiforme who have failed conventional therapy ...
Mazzilli glad Spider-Man off lineup cardBaltimore Sun
With SPA Agreement, Xenova Plans Two TransMID Phase IIIs May 11, 2004
Each of the trials is designed to enroll 323 patients with non-resectable, progressive or recurrent glioblastoma multiforme who have failed conventional therapy ... BioWorld Online (subscription) - May 11, 2004
... Each of the trials is designed to enroll 323 patients with non-resectable, progressive or recurrent glioblastoma multiforme who have failed conventional therapy ...
Mazzilli glad Spider-Man off lineup cardBaltimore Sun
Mazzilli glad Spider-Man off lineup card May 8, 2004
Ramsay appeared in 43 games with the Seattle Mariners in 1999 and 2000, but he missed the entire 2002 season after doctors diagnosed glioblastoma multiforme, a ... Baltimore Sun
Fitchburg woman's family suing UMass over kidney transplant May 14, 2004
He said his mother wasn't told before the Feb. 4, 2002, transplant that the donor had died of a fast-moving form of brain cancer called glioblastoma. ... Fitchburg Sentinel
Lawsuit Filed After Diseased Organs Allegedly Kill 3 Patients May 13, 2004
All the patients received transplanted organs from the same cancer-ridden donor. The donor died of glioblastoma, a highly malignant brain tumor. ... Boston Channel.com
Barth has had setbacks May 12, 2004
...said. "He won't quit.". His tumor's official name is Glioblastoma Multiforme, the most aggressive brain tumor a person can have. In ... Long Beach Press-Telegram
Community rallies to care for Lori's girls May 12, 2004
They didn’t think she was going to make it out of that,� Kirstin said. Doctors realized Lori had a glioblastoma, a very aggressive tumor. ... Silverton Appeal Tribune
Alert me when: May 12, 2004
...to determine whether areas of apparently increased tumor vascularity, as identified on 8-T gradient-echo (GE) imaging of a known glioblastoma multiforme (GBM ... American Journal of Neuroradiology - May 12, 2004
... to determine whether areas of apparently increased tumor vascularity, as identified on 8-T gradient-echo (GE) imaging of a known glioblastoma multiforme (GBM ...
Finding may lead to custom cancer treatmentsMSNBC - Apr 29, 2004
... be targeted by Iressa. Possibilities include a brain tumor called glioblastoma and head and neck cancer. At least one pharmaceutical ...
Reports Show Way to Custom-Tailor Cancer TreatmentReuters
Finding may lead to custom cancer treatments Apr 29, 2004
...be targeted by Iressa. Possibilities include a brain tumor called glioblastoma and head and neck cancer. At least one pharmaceutical ... MSNBC - Apr 29, 2004
... be targeted by Iressa. Possibilities include a brain tumor called glioblastoma and head and neck cancer. At least one pharmaceutical ...
Reports Show Way to Custom-Tailor Cancer TreatmentReuters
Reports Show Way to Custom-Tailor Cancer Treatment Apr 29, 2004
...be targeted by Iressa. Possibilities include a brain tumor called glioblastoma and head and neck cancer. Sellers said the finding ... Reuters
Success of lung cancer drug linked to genetic mutation Apr 30, 2004
Similar mutations are also present in some patients with other cancers, including head and neck cancer and a brain tumor called glioblastoma. ... Kansas City Star (subscription)
New lung cancer drug helps patients with specific gene defect, ... Apr 30, 2004
Similar mutations are present in some patients with other cancers, including head and neck cancer and a brain tumor called glioblastoma. ... San Francisco Chronicle
Resources from the National Cancer Institute on glioblastoma:
Cancer.gov Clinical Trials (PDQ®). Important: This information is intended mainly
for use by doctors and other health care professionals. If ...
Cancer.gov Phase I Study of Boron Neutron Capture Therapy and Borocaptate Sodium Following Craniotomy
with Gross Total Resection in Patients With Glioblastoma Multiforme. ...
Cancer.gov Phase II Study of Radiotherapy Followed By Sustained Release Intratumoral Bleomycin
in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme. ...
Cancer.gov Study of Accelerated Radiotherapy With Conformal Stereotactic Radiotherapy Boost
Followed by Carmustine in Patients With Supratentorial Glioblastoma Multiforme. ...
Cancer.gov Phase I/II Study of Conformal Radiotherapy and Carmustine in Patients With
Supratentorial Glioblastoma Multiforme. Date Last Modified: 2003-09-15. ...
Cancer.gov Phase I/II Study of Gefitinib and Radiotherapy in Patients With Glioblastoma
Multiforme. Date Last Modified: 2004-05-12. Date First Published: 2002-12-21. ...
Cancer.gov - Adult Brain Tumors (PDQ®): Treatment Anaplastic astrocytomas have cells that look very different from normal cells and
that grow more rapidly. Glioblastoma multiforme. ... Adult Glioblastoma Multiforme. ...
Cancer.gov Phase I/II Study of Oxaliplatin Followed By Radiotherapy in Patients With
Newly Diagnosed Glioblastoma Multiforme. Date Last Modified: 2003-09-17. ...
Cancer.gov A maximum of 140 patients (31-49 with anaplastic astrocytoma, 22-81 with glioblastoma
multiforme, and 10 dose-escalation patients) will be accrued for this ...
Cancer.gov Phase I Study of Intratumor BG00001 (Adenoviral Vector Encoding Human Interferon
beta) in Patients With Recurrent or Progressive Glioblastoma Multiforme. ...
|
|
|
